Global Regulatory Operations

Our proven processes and tools are designed to designed to deliver fast and high-quality submissions.

I appreciate your flexibility! I wish all CRO’s were as efficient as the MMS team.
Regulatory Operations Head
Leading Pharmaceutical Sponsor

Regulatory Operations experts at MMS are skilled at managing, preparing, and submitting a diverse array of regulatory submissions to global health authorities. Our team is committed to providing sponsors with personalized, automated, and forward-thinking end-to-end regulatory build and submission solutions by serving as an integrated extension of our Sponsor teams. Throughout the product life cycle, our validated document management systems, industry-leading eCTD publishing and validation systems, and on-the-ground support with certified teams allow for unparalleled accuracy and efficiency. MMS supports submissions in the US, Canada, AU, Swiss, EA/EU, UK, and GCC regions, among others.

Our preclinical to late-stage commercialization and global market expansion services include:

  • Pre-clinical support, including request for application numbers, filing intent to submit applications, meeting requests and briefing packages, and developing submission content plans.
  • Clinical development and global submissions of study authorization applications, including initial trial applications and amendments, scientific advice submissions, special designation submissions like fast-track designation, and special protocol assessment requests etc.
  • Submission management of marketing authorization applications, responses to requests for information, and post-approval life-cycle management and supplements, Advertisement Promotion, and SPL submissions.
Document Publishing

Our skilled team of experts prepares eCTD-ready documents using advanced automation, ensuring minimal effort and maximum quality. Our published documents comply with global regulatory requirements with enhanced submission navigation, aiding agency reviewers. Native files are processed to ensure submission readiness, including tasks such as bookmarking, linking, OCR, scaling, updating document properties, and optimizing. This process supports complex documents like RMPs, CRFs, and CSRs with enhanced and automated publishing capabilities.

We are proficient in a wide variety of document management and RIMS systems that Sponsors utilize, and we offer customized services tailored to meet their specific needs. For instance, we prepare native Word documents for automated rendering into submission-ready formats. Our robust QC processes ensure accurate PDF navigation and validation, and we have specialized checks for submission readiness, including anonymized documents and those intended for public disclosure.

End-to-end support: Submission Publishing and Agency Delivery

MMS experts provide end-to-end support from content plan preparation, document procurement, submission build, validation, and a 100% quality control check.  Our adaptable and proven processes, combined with our commitment to KPI-driven quality deliverables, ensure that our specialists generate submissions of the highest quality. Our project leads take on the critical task of coordinating the submission review with sponsor teams, seamlessly addressing client requirements to ensure a smooth submission process.

From document authoring to compilation, MMS proactively engages with sponsor teams to streamline activities, incorporate cross-departmental efficiencies, and simultaneously build multiple health authority applications, ensuring smooth regulatory submissions worldwide. Our global teams are always prepared to accommodate possible delays or risks that may set back the submission timeline. Our proven process and extensive experience ensure maximum reuse of published files and submission dossiers with minimum effort to clone and submit to diverse global regions. Your MMS  regulatory colleagues continuously monitor for risks and anticipate regulatory issues, proactively addressing them to ensure submissions are prepared and submitted according to, or ahead of, the sponsor’s or agency’s timeline.

eCTD Lifecycle Management

Maintain the most up-to-date documents and associated information for your application in one place, ensuring every health authority has what they need at all times. This includes ongoing maintenance of all future sequences, such as amendments, supplements, variations, Ad-Promos, SPLs, and more.

Submission Delivery

Our global teams are experienced with most major agency electronic portals, enabling us to dispatch submissions around the clock. This includes gateway portals such as the US FDA, Health Canada, EMA, MHRA, IRIS, and CTIS, among others.

Document Management

We understand platforms from simple document sharing systems to advanced RIMS solutions for document management and submission archival. Our specialists support multiple document management systems and provide custom support ensuing compliance to MMS and/or Sponsor’s archival processes.

Regulatory Information Management

The MMS team is well-trained and experienced and supports several regulatory information management (RIM) systems for our sponsors. Our RIM services include the creation of submission records along with the archival process, object creation and management (such as Events, Activities, Applications, Regulatory objectives, and Registrations), as well as data migration activities.

Sponsors are inclined to use systems that enable a centralized process to plan, manage, and track regulatory data, documents, and activities. Our teams leverage knowledge gained from working on different RIMS systems to provide dynamic support and comply with the Sponsors’ regulatory archival needs.

MMS regulatory specialists can help Sponsors identify gaps, set up structured and logical processes, develop SOPs and guidance materials, and train different vendor teams.

Suggested For You

perspectives

December 17th, 2024

Oncology Drug Development: Webinar Learnings on the Use of Expedited Pathways and Oncology Center of Excellence Programs

perspectives

December 11th, 2024

Why Emerging Biotech Companies are Increasingly Turning to Specialized Data CROs

regulatory intelligence

December 4th, 2024

FDA Issues Detailed Guidance on Development of Gene Therapy Products

news

December 4th, 2024

AI in Pharma and Innovative Leadership Were on Display at the Biennial MMS Scientific Symposium

perspectives

November 26th, 2024

Finding GRASEland: Navigating the New Regulatory Path for Grandfathered OTC Drugs 

perspectives

November 21st, 2024

Essential Nonclinical Strategies for Cell and Gene Therapy (CGT) Success

news

November 19th, 2024

MMS Recognized as a Top Workplace by Detroit Free Press and USA Today Network for the Fourth Consecutive Year

perspectives

November 12th, 2024

REMS Logic Modeling: Applying FDA Guidance from November 2024 CDER Webinar

news

November 8th, 2024

MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

perspectives

November 6th, 2024

How to Successfully Manage Rescue Studies and Turn Around Clinical Trials Facing Failure

perspectives

October 29th, 2024

Why Outsourcing QC of Regulatory and Medical Writing Documents is a Competitive Advantage for Large Pharma Companies

perspectives

October 22nd, 2024

Choosing the Right Clinical Trial Design: A Crucial Step in Protocol Development